Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death‐ligand 1 inhibitors in non–small cell lung cancer
Article in Cancer (February 2023)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in Cancer (February 2023)
Article in Cancers (December 2022)
Article in BioDrugs (December 2022)